The GDNF-GFRα1 complex promotes the development of hippocampal dendritic arbors and spines via NCAM

The formation of synaptic connections during nervous system development requires the precise control of dendrite growth and synapse formation. Although glial cell line-derived neurotrophic factor (GDNF) and its receptor GFRα1 are expressed in the forebrain, the role of this system in the hippocampus remains unclear. Here, we investigated the consequences of GFRα1 deficiency for the development of hippocampal connections. Analysis of conditional Gfra1 knockout mice shows a reduction in dendritic length and complexity, as well as a decrease in postsynaptic density specializations and in the synaptic localization of postsynaptic proteins in hippocampal neurons. Gain- and loss-of-function assays demonstrate that the GDNF-GFRα1 complex promotes dendritic growth and postsynaptic differentiation in cultured hippocampal neurons. Finally, in vitro assays revealed that GDNF-GFRα1- induced dendrite growth and spine formation are mediated by NCAM signaling. Taken together, our results indicate that the GDNF-GFRα1 complex is essential for proper hippocampal circuit development.Fil: Irala, Dolores. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia "Prof. Eduardo de Robertis". Universidad de Buenos Aires. Facultad de Medicina. Instituto de Biología Celular y Neurociencia; ArgentinaFil: Bonafina, Antonela. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia "Prof. Eduardo de Robertis". Universidad de Buenos Aires. Facultad de Medicina. Instituto de Biología Celular y Neurociencia; ArgentinaFil: Fontanet, Paula. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia "Prof. Eduardo de Robertis". Universidad de Buenos Aires. Facultad de Medicina. Instituto de Biología Celular y Neurociencia; ArgentinaFil: Alsina, Fernando Cruz. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia "Prof. Eduardo de Robertis". Universidad de Buenos Aires. Facultad de Medicina. Instituto de Biología Celular y Neurociencia; ArgentinaFil: Paratcha, Gustavo. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia "Prof. Eduardo de Robertis". Universidad de Buenos Aires. Facultad de Medicina. Instituto de Biología Celular y Neurociencia; ArgentinaFil: Ledda, Maria Fernanda. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia "Prof. Eduardo de Robertis". Universidad de Buenos Aires. Facultad de Medicina. Instituto de Biología Celular y Neurociencia; Argentin

Pea3 transcription factor family members Etv4 Etv5 mediate retrograde signalling and axonal growth of DRG sensory neurons in response to NGF

Nerve growth factor (NGF) is a target-derived neurotrophic growth factor that controls many aspects of sensory and sympathetic neuronal development. The identification of transcription factors and downstream target genes that mediate NGF-dependent neuronal differentiation and target field innervation is currently a major challenge. Here, we show that the Pea3 transcription factor family members Etv4 and Etv5 are expressed by developing TrkA-positive dorsal root ganglion (DRG) neurons during the period of target innervation. Real-time PCR assays indicated that Etv4 and Etv5 mRNAs are significantly induced by NGF in different neuronal cells, suggesting that they could be involved in the biological responses induced by this neurotrophin. Interestingly, distal axon application of NGF in compartmentalized cultures of rat DRG sensory neurons was sufficient to induce a significant increase in Etv4 and Etv5 mRNA expression. Pharmacological assays also revealed that activation of MEK/ERK (MAPK) pathway is required for Etv4 and Etv5 gene induction in response to NGF. Downregulation of Etv4 and Etv5 using small interference RNA knockdown experiments inhibited NGF-induced neurite outgrowth of rat sensory neurons, while overexpression of full-length Etv4 or Etv5 potentiated neuronal differentiation in response to this neurotrophin. Together, these data establish Etv4 and Etv5 as essential molecules of the transcriptional program linking neurotrophin signaling to sensory neuronal differentiation, and suggest that they can be involved in NGF-mediated target innervation.Fil: Fontanet, Paula. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencias "profesor Eduardo de Robertis"; ArgentinaFil: Irala, Dolores. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencias "profesor Eduardo de Robertis"; ArgentinaFil: Alsina, Fernando Cruz. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencias "profesor Eduardo de Robertis"; ArgentinaFil: Paratcha, Gustavo. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencias "profesor Eduardo de Robertis"; Argentina. Karolinska Huddinge Hospital. Karolinska Institutet; SueciaFil: Ledda, Maria Fernanda. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencias "profesor Eduardo de Robertis"; Argentina. Karolinska Huddinge Hospital. Karolinska Institutet; Sueci

Lrig1 and lrig3 cooperate to control ret receptor signaling, sensory axonal growth and epidermal innervations

Negative feedback loops represent a regulatory mechanism that guarantees that signaling thresholds are compatible with a physiological response. Previously, we established that Lrig1 acts through this mechanism to inhibit Ret activity. However, it is unclear whether other Lrig family members play similar roles. Here, we show that Lrig1 and Lrig3 are co-expressed in Ret-positive mouse dorsal root ganglion (DRG) neurons. Lrig3, like Lrig1, interacts with Ret and inhibits GDNF/Ret signaling. Treatment of DRG neurons with GDNF ligands induces a significant increase in the expression of Lrig1 and Lrig3. Our findings show that, whereas a single deletion of either Lrig1 or Lrig3 fails to promote Ret-mediated axonal growth, haploinsufficiency of Lrig1 in Lrig3 mutants significantly potentiates Ret signaling and axonal growth of DRG neurons in response to GDNF ligands. We observe that Lrig1 and Lrig3 act redundantly to ensure proper cutaneous innervation of nonpeptidergic axons and behavioral sensitivity to cold, which correlates with a significant increase in the expression of the cold-responsive channel TrpA1. Together, our findings provide insights into the in vivo functions through which Lrig genes control morphology, connectivity and function in sensory neurons.Fil: de Vincenti, Ana Paula. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia "Prof. Eduardo de Robertis". Universidad de Buenos Aires. Facultad de Medicina. Instituto de Biología Celular y Neurociencia; ArgentinaFil: Alsina, Fernando Cruz. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia "Prof. Eduardo de Robertis". Universidad de Buenos Aires. Facultad de Medicina. Instituto de Biología Celular y Neurociencia; ArgentinaFil: Ferrero Restelli, Facundo Nahuel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia "Prof. Eduardo de Robertis". Universidad de Buenos Aires. Facultad de Medicina. Instituto de Biología Celular y Neurociencia; ArgentinaFil: Hedman, Håkan. Universidad de Umea; SueciaFil: Ledda, Maria Fernanda. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires; ArgentinaFil: Paratcha, Gustavo. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires; Argentin

LRIG1 negatively regulates RET mutants and is downregulated in thyroid cancer

Papillary thyroid carcinoma (PTC) and medullary thyroid carcinoma (MTC) are characterized by genomic rearrangements and point mutations in the proto-oncogene RET. Leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) is a suppressor of various receptor tyrosine kinases, including RET. LRIG1 expression levels are associated with patient survival in many cancer types. In the present study, we investigated whether the oncogenic RET mutants RET2A (C634R) and RET2B (M918T) were regulated by LRIG1, and the possible effects of LRIG1 expression in thyroid cancer were investigated in three different clinical cohorts and in a RET2B-driven mouse model of MTC. LRIG1 was shown to physically interact with both RET2A and RET2B and to restrict their ligand-independent activation. LRIG1 mRNA levels were downregulated in PTC and MTC compared to normal thyroid gland tissue. There was no apparent association between LRIG1 RNA or protein expression levels and patient survival in the studied cohorts. The transgenic RET2B mice developed pre-cancerous medullary thyroid lesions at a high frequency (36%); however, no overt cancers were observed. There was no significant difference in the incidence of pre-cancerous lesions between Lrig1 wild-Type and Lrig1-deficient RET2B mice. In conclusion, the findings that LRIG1 is a negative regulator of RET2A and RET2B and is also downregulated in PTC and MTC may suggest that LRIG1 functions as a thyroid tumor suppressor.Fil: Lindquist, David. Universidad de Umea; SueciaFil: Alsina, Fernando Cruz. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia "Prof. Eduardo de Robertis". Universidad de Buenos Aires. Facultad de Medicina. Instituto de Biología Celular y Neurociencia; ArgentinaFil: Herdenberg, Carl. Universidad de Umea; SueciaFil: Larsson, Catharina. Karolinska University Hospital;Fil: Höppener, Jo. University Medical Center Utrecht;Fil: Wang, Na. Karolinska University Hospital;Fil: Paratcha, Gustavo. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia "Prof. Eduardo de Robertis". Universidad de Buenos Aires. Facultad de Medicina. Instituto de Biología Celular y Neurociencia; ArgentinaFil: Tarján, Miklós. Falu Lasarett; SueciaFil: Tot, Tibor. Falu Lasarett; SueciaFil: Henriksson, Roger. Universidad de Umea; SueciaFil: Hedman, Håkan. Universidad de Umea; Sueci

Correction : Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10, 2885

The authors wish to make the following corrections to this paper [...]

Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain : Large-Scale Epidemiological Study

(1) Aims: To assess the incidence of inflammatory bowel disease (IBD) in Spain, to describe the main epidemiological and clinical characteristics at diagnosis and the evolution of the disease, and to explore the use of drug treatments. (2) Methods: Prospective, population-based nationwide registry. Adult patients diagnosed with IBD-Crohn's disease (CD), ulcerative colitis (UC) or IBD unclassified (IBD-U)-during 2017 in Spain were included and were followed-up for 1 year. (3) Results: We identified 3611 incident cases of IBD diagnosed during 2017 in 108 hospitals covering over 22 million inhabitants. The overall incidence (cases/100,000 person-years) was 16 for IBD, 7.5 for CD, 8 for UC, and 0.5 for IBD-U; 53% of patients were male and median age was 43 years (interquartile range = 31-56 years). During a median 12-month follow-up, 34% of patients were treated with systemic steroids, 25% with immunomodulators, 15% with biologics and 5.6% underwent surgery. The percentage of patients under these treatments was significantly higher in CD than UC and IBD-U. Use of systemic steroids and biologics was significantly higher in hospitals with high resources. In total, 28% of patients were hospitalized (35% CD and 22% UC patients, p < 0.01). (4) Conclusion: The incidence of IBD in Spain is rather high and similar to that reported in Northern Europe. IBD patients require substantial therapeutic resources, which are greater in CD and in hospitals with high resources, and much higher than previously reported. One third of patients are hospitalized in the first year after diagnosis and a relevant proportion undergo surgery

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

Objectives: The objective of this study was to estimate the association between tocilizumab or corticosteroids and the risk of intubation or death in patients with coronavirus disease 19 (COVID-19) with a hyperinflammatory state according to clinical and laboratory parameters. Methods: A cohort study was performed in 60 Spanish hospitals including 778 patients with COVID-19 and clinical and laboratory data indicative of a hyperinflammatory state. Treatment was mainly with tocilizumab, an intermediate-high dose of corticosteroids (IHDC), a pulse dose of corticosteroids (PDC), combination therapy, or no treatment. Primary outcome was intubation or death; follow-up was 21 days. Propensity score-adjusted estimations using Cox regression (logistic regression if needed) were calculated. Propensity scores were used as confounders, matching variables and for the inverse probability of treatment weights (IPTWs). Results: In all, 88, 117, 78 and 151 patients treated with tocilizumab, IHDC, PDC, and combination therapy, respectively, were compared with 344 untreated patients. The primary endpoint occurred in 10 (11.4%), 27 (23.1%), 12 (15.4%), 40 (25.6%) and 69 (21.1%), respectively. The IPTW-based hazard ratios (odds ratio for combination therapy) for the primary endpoint were 0.32 (95%CI 0.22-0.47; p < 0.001) for tocilizumab, 0.82 (0.71-1.30; p 0.82) for IHDC, 0.61 (0.43-0.86; p 0.006) for PDC, and 1.17 (0.86-1.58; p 0.30) for combination therapy. Other applications of the propensity score provided similar results, but were not significant for PDC. Tocilizumab was also associated with lower hazard of death alone in IPTW analysis (0.07; 0.02-0.17; p < 0.001). Conclusions: Tocilizumab might be useful in COVID-19 patients with a hyperinflammatory state and should be prioritized for randomized trials in this situatio

Negative regulation of neurotrophic factor receptor signaling in developing neurons

Los factores neurotróficos son proteínas solubles principalmente conocidas por su participación en el mantenimiento, sobrevida, diferenciación y maduración sináptica de diferentes subpoblaciones neuronales. Distintas familias de factores neurotróficos han sido identificadas en el sistema nervioso de mamíferos, entre las que se destacan el grupo de las neurotrofinas (NGF, BDNF, NT3, NT4) y la familia del factor neurotrófico derivado de la glia (GDNF, NRTN, ARTN, PSPN). Las señales inducidas por estos ligandos involucran la activación de receptores conteniendo una actividad tirosina kinasa intrínseca, un evento de señalización clave para controlar la fisiología celular y orquestar el desarrollo del sistema nervioso. Un fuerte control y regulación de la actividad de los receptores tirosina kinasa (RTK) es crucial para garantizar la homeostasis celular y un apropiado desarrollo neuronal, ya que tanto alteraciones funcionales de estos receptores por mutaciones en los correspondientes genes como fallas en los mecanismos que restringen su activación, podrían contribuir a la patogénesis de ciertos tipos de cáncer y de enfermedades neurológicas. De esta manera, para evitar errores de señalización que finalmente lleven a comportamientos celulares aberrantes y patologías, los mecanismos celulares han evolucionado para permitir que apropiados niveles de activación de estos receptores sean alcanzados y mantenidos por un período de tiempo compatible con la inducción de una respuesta fisiológica. El objetivo de la presente tesis consistió en identificar y caracterizar nuevos mecanismos que restringen la activación de receptores para factores neurotróficos en neuronas en desarrollo, como una vía para entender la patogénesis de diferentes enfermedades neurológicas, y así contribuir al desarrollo de nuevas terapias regenerativas. Inicialmente, identificamos y caracterizamos a la proteína Sprouty4 como un inhibidor endógeno de la señalización y el crecimiento axonal inducidos por NGF y su receptor TrkA en neuronas sensoriales de los ganglios de la raíz dorsal (DRG). Por otro lado, nosotros también analizamos el rol de los miembros de la familia de proteínas Lrig – Lrig1, Lrig2 y Lrig3 – como moduladores endógenos del estado de activación de receptores para factores neurotróficos. Las proteínas Lrig pertenecen a una emergente superfamilia de proteínas transmembrana enriquecidas en sistema nervioso que contienen dominios inmunoglobulina (Ig) y repeticiones ricas en leucina (LRR - Leucine-rich repeats). En este sentido, identificamos a Lrig1 como un regulador negativo de la señalización y los efectos biológicos inducidos por BDNF y su receptor TrkB en neuronas hipocampales. Notablemente, hemos determinado que los ratones transgénicos deficientes para Lrig1 poseen una mayor arborización dendrítica en las neuronas piramidales del hipocampo que correlaciona con defectos en su comportamiento de interacción social, aportando nuevas evidencias de su relevancia fisiológica. Por último, realizamos experimentos que demuestran que los tres miembros de la familia Lrig, cooperarían para inhibir el crecimiento neurítico inducido por GDNF, controlando el estado de activación de su receptor tirosina kinasa Ret en células neuronales. De esta manera, en este trabajo de tesis doctoral hemos identificado nuevos determinantes moleculares relevantes para el control de la conectividad y el armado de los circuitos neuronales, a través de la regulación de procesos de crecimiento axonal y dendríticos inducidos por factores neurotróficos en el sistema nervioso central y periférico. Palabras clave: RTK, factores neurotróficos, Lrig, Sprouty4, NGF, BDNF, GDNF, Ret, TrkA, TrkB, hipocampo, ganglios de la raíz dorsal (DRG).Neurotrophic factors are soluble proteins mainly known for their roles in the maintenance, survival, differentiation and synaptic maturation of different neuronal subpopulations. Different families of neurotrophic factors have been identified in the mammalian nervous system, including the neurotrophins (NGF, BDNF, NT3, NT4) and the glial cell-line derived neurotrophic factor family ligands (GDNF, NRTN, ARTN, PSPN). Signaling induced by these ligands involves the activation of receptors containing a tyrosine kinase intrinsic activity, a key event to control cell physiology and orchestrate the development of the nervous system. A tight control and regulation of the activity of receptor tyrosine kinases (RTK) are crucial to ensure proper cell homeostasis and neuronal development, as both functional alterations of these receptors by gene mutations and failures on the mechanisms that restrict their activation may contribute to the pathogenesis of certain types of cancer and neurological diseases. Therefore, to avoid signaling errors that could eventually lead to aberrant and pathological cellular behaviors, the cellular mechanisms have evolved to allow that appropriate signaling thresholds are reached and maintained for a period of time compatible with the induction of a physiological response. The aim of this thesis was to identify and characterize new mechanisms that restrict the activation of neurotrophic factor receptors in developing neurons, as a way to understand the pathogenesis of some neurological diseases, thus contributing to the development of new regenerative therapies. First, we identified and characterized Sprouty4 protein as an endogenous inhibitor of TrkA-dependent downstream signaling and NGF-induced axonal growth of primary dorsal root ganglia (DRG) sensory neurons. On the other hand, we also analyzed the role of Lrig protein family members – Lrig1, Lrig2 and Lrig3 – as endogenous modulators of neurotrophic factor receptor activation. Lrig proteins belong to a novel superfamily of transmembrane proteins enriched in nervous system containing immunoglobulin-like (Ig) and leucine-rich repeat domains (LRR). Here, we identified Lrig1 as a negative regulator of TrkB signaling and biological effects induced by BDNF in hippocampal neurons. Interestingly, we have determined that Lrig1-null transgenic mice have increased dendrite morphogenesis and dendritic arborization of CA1 and CA3 hippocampal pyramidal neurons, suggesting that Lrig1 could increase the repertoire of TrkB signaling outputs to allow hippocampal neurons to sculpt distinctive dendrite patterns. In addition, Lrig1 ablation was also associated with social motivation/interaction deficits, providing new insights into its physiological importance. Finally, we conducted a set of experiments showing that the three Lrig family members cooperate to inhibit GDNF-promoted neurite outgrowth by controlling the activation state of the tyrosine kinase receptor Ret in neuronal cells. In conclusion, in this manuscript we have identified novel molecular determinants, relevant to control connectivity and neural circuits assembly through the regulation of axonal and dendritic growth induced by neurotrophic factors in peripheral and central nervous system. key words: RTK, Neurotrophic factors, Lrig, Sprouty4, NGF, BDNF, GDNF, Ret, TrkA, TrkB, hippocampus, dorsal root ganglia (DRG).Fil:Alsina, Fernando Cruz. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina

New insights into the control of neurotrophic growth factor receptor signaling: Implications for nervous system development and repair

Neurotrophic growth factors control neuronal development by activating specific receptor tyrosine kinase positive signaling pathways, such as Ras-MAPK and PI3K-Akt cascades. Once activated, neurotrophic factor receptors also trigger a cascade of molecular events, named negative receptor signaling, that restricts the intensity of the positive signals and modulates cellular behavior. Thus, to avoid signaling errors that ultimately could lead to aberrant neuronal physiology and disease, negative signaling mechanisms have evolved to ensure that suitable thresholds of neuronal stimulation are achieved and maintained during right periods of time. Recent findings have revealed that neurotrophic factor receptor signaling is tightly modulated through the coordinated action of many different protein regulators that limit or potentiate signal propagation in spatially and temporally controlled manners, acting at specific points after receptor engagement. In this review, we discuss progress in this field, highlighting the importance of these modulators in axonal growth, guidance, neural connectivity, and nervous system regeneration.Fil: Alsina, Fernando Cruz. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia ; ArgentinaFil: Ledda, Maria Fernanda. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia ; ArgentinaFil: Paratcha, Gustavo. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia ; Argentin